Lori Minasian, MD, FACP

Lori Minasian, MD, FACP

Photo of Lori Minasian
Lori Minasian, MD, FACP
Deputy Director
(240) 276-7053
(240) 276-7846
5E342

View publications by Lori Minasian

Dr. Lori Minasian, Deputy Director for the Division of Cancer Prevention, is a board-certified medical oncologist, who for 15 years led the NCI’s Community Clinical Oncology Program. This program is a community-based clinical trials network created in 1983 as a mechanism for community physicians to partner with academic investigators for the purpose of accelerating the implementation of NCI clinical trials in cancer treatment, prevention and control.

As a leader in cancer clinical trials, she has served on multiple internal NCI committees and external working groups evaluating the clinical and scientific needs and operational efficiency of clinical trials methods and processes. She has served in an advisory capacity for the NIH Roadmap and the development of clinical trials networks at other NIH institutes. She is one of the senior staff involved in conceptualization and development of the Patient Reported Outcomes version of the Common Terminology Criteria for Adverse Event Reporting, a project emphasizing the importance of incorporating the patient’s perception into real-time reporting of adverse events.

Because the practice of oncology is rapidly evolving, Dr. Minasian maintains her clinical skills by attending in the Medical Ovarian Cancer Clinic at the NIH Clinical Center. She is an active member of the clinical team involved in patient care, the development and implementation of clinical trials using novel agents, and teaching the NCI oncology fellows.